Cargando…
Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study
Regular blood transfusion is the mainstay of treatment in transfusion-dependent β-thalassemia (TDT); however, transfusions culminate in an array of serious complications. Therefore, a single-arm, non-randomized clinical trial was conducted in hydroxyurea refractory TDT patients to explore the long-t...
Autores principales: | Ali, Zahid, Ismail, Mohammad, Rehman, Inayat Ur, Rani, Gulab Fatima, Ali, Muhammad, Khan, Muhammad Tariq Masood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442319/ https://www.ncbi.nlm.nih.gov/pubmed/37604857 http://dx.doi.org/10.1038/s41598-023-40849-4 |
Ejemplares similares
-
Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial
por: Chen, Jiang-Ming, et al.
Publicado: (2021) -
Challenges in transfusion and the role of Thalidomide in E‐β‐Thalassemia—A case report
por: Javed, Rizwan, et al.
Publicado: (2020) -
Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia
por: Ansari, Saqib H., et al.
Publicado: (2022) -
The TVGH-NYCU Thal-Classifier: Development of a Machine-Learning Classifier for Differentiating Thalassemia and Non-Thalassemia Patients
por: Fu, Yi-Kai, et al.
Publicado: (2021) -
Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study
por: Li, Xinyu, et al.
Publicado: (2021)